SMP-33693

• UNSPSC Description:

  SMP-33693 is a Drug-Linker Conjugate for ADC with a low payload shedding rate and has in vivo tumor inhibitory effects on ovarian cancer, gastric cancer, and breast cancer[1].

• Target Antigen:

  Drug-Linker Conjugates for ADC

• Type:

  ADC Related

• Related Pathways:

  Antibody-drug Conjugate/ADC Related

• Applications:

  Cancer-programmed cell death

• Field of Research:

  cancer

• Assay Protocol:

  https://www.medchemexpress.com/smp-33693.html

• Solubility:

  10 mM in DMSO

• Smiles:

  O=C(NC[C@@H](O)C[C@H]1O[C@@H](C[C@H]2O[C@@H](CC[C@H]3C(C[C@H](CC[C@]45C[C@](O6)([H])[C@@H]7O4)O3)=C)C[C@@H](C)C2=C)[C@H](CC(C[C@H]8CC[C@@]9([H])[C@]([C@H](O5)C6C7O9)([H])O8)=O)[C@H]1OC)CNC([C@H](CC%10=CC=CC=C%10)NC(CNC(CNC(CN%11CCOCCOCCN(C(CCCCCN%12C(C=CC%12=O)=O)=O)CCOCCOCC%11)=O)=O)=O)=O

• Molecular Weight:

  1543.79

• Shipping Conditions:

  Room temperature

• Clinical Information:

  No Development Reported